"Nafcilline"@en . "Staphylococcus aureus"@en . "Enteric bacteria and other eubacteria"@en . "Nafcillin is primarily eliminated by nonrenal routes, namely hepatic inactivation and excretion in the bile."@en . "89.9 ±1.5%"@en . "(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"@en . . . . . . "Nafcillin"@en . . . . . . . . . . . . . . . . . "147-52-4"@en . . . . . . . . . "Penicillinase-resistant penicillins exert a bactericidal action against penicillin-susceptible microorganisms during the state of active multiplication. All penicillins inhibit the biosynthesis of the bacterial cell wall."@en . . . . . . . "Naphcillin"@en . . . . . "(2-Ethoxy-1-naphthyl)penicillin"@en . "Serious toxicity is unlikely following large doses of nafcillin. Acute ingestion of large doses of nafcillin may cause nausea, vomiting, diarrhea and abdominal pain. Acute oliguric renal failure and hematuria may occur following large doses."@en . . . . . . . . . . " "@en . "For the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs."@en . . "(2-Ethoxy-1-naphthalenyl)penicillin"@en . "Nafcilina"@en . . . . . . . "approved"@en . . " "@en . "A semi-synthetic antibiotic related to penicillin. [PubChem]"@en . . . "6-(2-Ethoxy-1-naphthamido)penicillanic acid"@en . . . . . . . . . . . . . . . . "The serum half-life of nafcillin administered by the intravenous route ranged from 33 to 61 minutes as measured in three separate studies."@en . . "Nafcillinum"@en .